NODAL MARGINAL ZONE B-CELL LYMPHOMA RECURRENT

NODAL MARGINAL ZONE B-CELL LYMPHOMA RECURRENT was reported 3 times

NODAL MARGINAL ZONE B-CELL LYMPHOMA RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Topoisomerase Inhibitor [EPC] 1 0.0000
1 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
2 Alkylating Drug [EPC] 2 0.0000
3 Azole Antifungal [EPC] 1 0.0000
4 Platinum-based Drug [EPC] 1 0.0000
5 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
6 Corticosteroid [EPC] 2 0.0000